Back
Crinetics Pharmaceuticals Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
CRNX
Crinetics Pharmaceuticals
Last Price:
56.06
Seasonality Move:
7.41%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Crinetics Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 25.7% based on the past 6 years of stock performance.
- Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Crinetics Pharmaceuticals Stock Undervalued?
The current Crinetics Pharmaceuticals [CRNX] share price is $57.03. The Score for CRNX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal. - CRNX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Crinetics Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Crinetics Pharmaceuticals has on average historically risen by 25.7% based on the past 6 years of stock performance.
Crinetics Pharmaceuticals Stock Rating
Buy
56
Crinetics Pharmaceuticals (CRNX)
is a Buy
Is Crinetics Pharmaceuticals overpriced?
- Crinetics Pharmaceuticals has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Crinetics Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crinetics.com
52-Week Data
52-Week High:
62.53
52-Week Low:
29.72
Prediction Charts
Market Cap:
5.29B
Price in USD:
57.03
Volume:
681.37K
Beta:
0.68
Technical Analysis
SMA50:
55.16
SMA100:
53.38
SMA200:
48.81
52-Wk Change:
90.48%
Stock Predictions
-
Is Crinetics Pharmaceuticals stock public?
Yes, Crinetics Pharmaceuticals is a publicly traded company. -
What is the Crinetics Pharmaceuticals stock quote today?
The Crinetics Pharmaceuticals stock price is 57.03 USD today. -
How to buy Crinetics Pharmaceuticals stock online?
You can buy Crinetics Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-4 | 56.17 | 56.82 | 58.00 | 55.21 |
| Nov-5 | 56.49 | 57.81 | 57.88 | 55.28 |
| Nov-6 | 60.03 | 59.16 | 60.91 | 58.58 |
| Nov-7 | 59.11 | 59.75 | 60.17 | 58.66 |
| Nov-8 | 59.60 | 60.69 | 60.93 | 58.98 |
| Nov-11 | 61.88 | 60.01 | 62.00 | 59.95 |
| Nov-12 | 59.99 | 58.78 | 60.48 | 58.21 |
| Nov-13 | 60.00 | 58.92 | 61.16 | 58.50 |
| Nov-14 | 58.28 | 59.66 | 62.53 | 58.17 |
| Nov-15 | 60.13 | 54.72 | 60.15 | 54.42 |
| Nov-18 | 54.35 | 53.70 | 55.05 | 52.85 |
| Nov-19 | 53.15 | 55.17 | 55.21 | 53.15 |
| Nov-20 | 55.33 | 56.07 | 56.43 | 54.64 |
| Nov-21 | 56.00 | 57.03 | 58.04 | 55.31 |
Crinetics Pharmaceuticals Earnings
Crinetics Pharmaceuticals Earnings Report: Per Share Crinetics Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Crinetics Pharmaceuticals Forecast Revenue Growth
Crinetics Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Crinetics Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.18 per share.
* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.